Workflow
Blade(BLDE) - 2023 Q3 - Quarterly Report

Financial Performance - Revenue for Q3 2023 reached 71,442,000,a5671,442,000, a 56% increase from 45,722,000 in Q3 2022[71] - Year-to-date revenue for the nine months ended September 30, 2023, was 177,702,000,up64177,702,000, up 64% from 107,985,000 in the same period of 2022[71] - For the three months ended September 30, 2023, Blade Air Mobility reported revenue of 30.71million,adecreasefrom30.71 million, a decrease from 45.72 million in the same period of 2022, representing a decline of approximately 33%[107] - Total revenue for the nine months ended September 30, 2023, was 177,702,000,a64.4177,702,000, a 64.4% increase from 107,985,000 in the same period of 2022[161] - Passenger segment revenue for the three months ended September 30, 2023, was 37,995,000,up48.937,995,000, up 48.9% from 25,503,000 in the same period of 2022[161] - Medical segment revenue for the three months ended September 30, 2023, was 33,447,000,anincreaseof65.033,447,000, an increase of 65.0% compared to 20,219,000 in the same period of 2022[161] Expenses and Losses - Cost of revenue for Q3 2023 was 55,863,000,comparedto55,863,000, compared to 36,456,000 in Q3 2022, reflecting a 53% increase[71] - Operating expenses totaled 78,890,000inQ32023,upfrom78,890,000 in Q3 2023, up from 56,150,000 in Q3 2022, marking a 40% increase[71] - The net loss for Q3 2023 was 289,000,asignificantimprovementcomparedtoanetlossof289,000, a significant improvement compared to a net loss of 9,245,000 in Q3 2022[71] - The company reported a net loss of 7,448millionforQ32023,animprovementfromalossof7,448 million for Q3 2023, an improvement from a loss of 10,428 million in Q3 2022[214] - Comprehensive loss for the nine months ended September 30, 2023, was 22,692,000,comparedtoacomprehensivelossof22,692,000, compared to a comprehensive loss of 13,209,000 for the same period in 2022[110] Assets and Liabilities - Cash and cash equivalents as of September 30, 2023, were 36.82million,downfrom36.82 million, down from 43.30 million at the end of 2022, reflecting a decrease of approximately 15%[104] - Total assets decreased to 317.51millionasofSeptember30,2023,from317.51 million as of September 30, 2023, from 325.03 million at the end of 2022, a decline of about 2.3%[104] - Total liabilities increased to 54.64millionasofSeptember30,2023,comparedto54.64 million as of September 30, 2023, compared to 50.54 million at the end of 2022, representing an increase of approximately 8.3%[104] - Blade's accumulated deficit increased to 125.81millionasofSeptember30,2023,from125.81 million as of September 30, 2023, from 103.68 million at the end of 2022, indicating a rise of approximately 21.3%[104] Stock and Equity - The company had 74,633,754 shares of common stock outstanding as of November 1, 2023, an increase from 71,660,617 shares at the end of 2022[93] - Total stockholders' equity as of September 30, 2023, was 262,877,000,adecreasefrom262,877,000, a decrease from 282,705,000 as of September 30, 2022[114] - The total number of common stock shares outstanding as of September 30, 2023, was 74,208,433, an increase from 71,506,665 shares as of September 30, 2022[114] Operational Insights - Blade plans to leverage expected lower operating costs of Electric Vertical Aircraft (EVA) to reduce flight prices and enhance market competitiveness[61] - The company aims to expand its passenger segment into dense urban areas, focusing on markets with existing air transportation infrastructure[60] - Blade's proprietary technology stack is designed to scale operations and improve logistics capabilities, facilitating future growth[52] - The company has experienced significant seasonality, with flight volume peaking in Q2 and Q3 due to summer travel[75] - Blade's asset-light business model allows for a seamless transition to EVA, which is expected to be quieter and emission-free[53] Other Financial Metrics - Blade's interest income for the three months ended September 30, 2023, was 2.15million,comparedto2.15 million, compared to 1.17 million in the same period of 2022, marking an increase of approximately 83.5%[107] - The company reported stock-based compensation of 9,348,000fortheninemonthsendedSeptember30,2023,comparedto9,348,000 for the nine months ended September 30, 2023, compared to 5,627,000 for the same period in 2022[118] - The company experienced a foreign currency translation adjustment loss of 1,500,000forthethreemonthsendedSeptember30,2023[110]Thecompanyrecognized1,500,000 for the three months ended September 30, 2023[110] - The company recognized 5,213 of revenue from the contract liability balance for the nine months ended September 30, 2023[157] - The company operates in three key product lines: Jet and Other, MediMobility Organ Transport, and Short Distance[158]